bioprinting

(redirected from bioprinter)
Also found in: Dictionary.

bioprinting

Using a specialized 3D printer to create human tissue. Instead of depositing liquid plastic or metal powder to build objects, the bioprinter deposits living cells layer by layer. Although decades away, the goal is to replace donor organs and their ongoing rejection issue with organs 3D printed from a patient's own cells. In the meantime, being able to routinely print tissue that can replace damaged areas in an organ is expected to materialize on a large scale. See tissue engineering.

Early Results
In 2002, Professor Makoto Nakamura of the University of Toyama, Japan determined that human cells were the same size as the ink droplets in an inkjet printer. In 2008, using a modified inkjet printer, Nakamura created a double-walled tube similar to a human blood vessel. In 2013 Cornell University printed ear cartilage that, after implantation, is expected to grow like normal tissue. Also in 2013, San Diego, CA-based Oragnovo printed tiny human liver samples. When subjected to diseases and drugs, the samples behave more like real organs than the commonly used 2D cultures and can determine a drug's efficacy before engaging in clinical trials. See organ on a chip and 3D printing.
References in periodicals archive ?
th], the Company announced a collaboration with the National Center for Advancing Translational Sciences (NCATS) and the National Eye Institute (NEI) to develop better and more clinically predictive tissue models using Organovo's NovoGen MMX Bioprinter.
Organovo is collaborating with the National Center for Advancing Translational Sciences (NCATS) and the National Eye Institute (NEI) to develop better and more clinically predictive tissue models using Organovo's NovoGen MMX Bioprinter.
It offers NovoGen MMX Bioprinter, a commercial hardware and software bioprinter platform to create tissues for bioprinting research and development.
Organovo's bioprinter was named one of the "Best Inventions of 2010" by TIME Magazine and Organovo has been recognized as one of the most innovative companies of 2012 by MIT's Technology Review.
The opportunity to allow those working towards significant breakthroughs in organ bioprinting to use the NovoGen MMX bioprinter is exciting, and we're happy to be able to establish this joint effort with Methuselah Foundation to enable greater access to Organovo's powerful platform.
His laboratory built the PrintAlive Bioprinter, which netted his research team the 2014 James Dyson Award for Canada, a design award that recognizes university student invention.
The tissue will also be used to study disease advancement, Murphy said and the tissue will be printed on the company's NovoGen MMX Bioprinter, which works much like an ink printer, except that it lays down living cells layer-by-layer.
The blood vessels were created through the use of the NovoGen MMX Bioprinter, Organovo's proprietary platform for the creation of 3D tissue constructs.
A 3D bioprinter is a medical device used to regenerate human tissues, which are created by human cells.
Partially offsetting these increases was a decrease in bioprinter development costs of approximately $0.
We are grateful to the Methuselah Foundation for their generous gift that gives those working towards significant breakthroughs in organ bioprinting an opportunity to use the NovoGen bioprinter and enable greater access to Organovo's powerful platform.
Modified Ink-jet Bioprinter for Skin Cells - Wake Forest Institute for Regenerative Medicine / Armed Forces Institute For Regenerative Medicine 6.